 Josiane Broussard
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Deprivation | 10 | 2024 | 174 | 3.470 |
Why?
| | Sleep | 15 | 2025 | 755 | 3.360 |
Why?
| | Circadian Rhythm | 12 | 2025 | 468 | 3.000 |
Why?
| | Insulin Resistance | 16 | 2024 | 1208 | 2.770 |
Why?
| | Obesity | 12 | 2024 | 2992 | 1.700 |
Why?
| | Sleep Wake Disorders | 3 | 2024 | 286 | 1.360 |
Why?
| | Insulin | 16 | 2024 | 2409 | 1.240 |
Why?
| | Blood Specimen Collection | 1 | 2025 | 41 | 0.940 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1724 | 0.930 |
Why?
| | Shift Work Schedule | 1 | 2025 | 12 | 0.920 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2015 | 159 | 0.920 |
Why?
| | Work Schedule Tolerance | 1 | 2025 | 49 | 0.910 |
Why?
| | Football | 1 | 2025 | 85 | 0.870 |
Why?
| | Wakefulness | 1 | 2023 | 125 | 0.790 |
Why?
| | Triglycerides | 1 | 2024 | 524 | 0.760 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2025 | 293 | 0.760 |
Why?
| | Dogs | 10 | 2020 | 413 | 0.750 |
Why?
| | Lipids | 2 | 2024 | 672 | 0.740 |
Why?
| | Postpartum Period | 1 | 2024 | 340 | 0.730 |
Why?
| | Athletes | 1 | 2025 | 423 | 0.720 |
Why?
| | Diet, High-Fat | 2 | 2020 | 247 | 0.710 |
Why?
| | Metabolic Diseases | 1 | 2022 | 108 | 0.690 |
Why?
| | Carnitine | 1 | 2021 | 84 | 0.680 |
Why?
| | Glucose Clamp Technique | 8 | 2024 | 195 | 0.640 |
Why?
| | Adipocytes | 2 | 2012 | 222 | 0.640 |
Why?
| | Hyperinsulinism | 3 | 2016 | 121 | 0.590 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 377 | 0.560 |
Why?
| | Blood Pressure | 1 | 2025 | 1786 | 0.550 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2017 | 99 | 0.540 |
Why?
| | Chronobiology Disorders | 1 | 2016 | 13 | 0.520 |
Why?
| | Cross-Over Studies | 4 | 2025 | 564 | 0.510 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2016 | 50 | 0.490 |
Why?
| | Energy Metabolism | 3 | 2023 | 922 | 0.490 |
Why?
| | Ghrelin | 1 | 2015 | 36 | 0.480 |
Why?
| | Eating | 3 | 2022 | 380 | 0.460 |
Why?
| | Exercise | 2 | 2024 | 2057 | 0.420 |
Why?
| | Glucose Tolerance Test | 5 | 2021 | 366 | 0.420 |
Why?
| | Lipid Metabolism | 2 | 2021 | 518 | 0.400 |
Why?
| | Sphingolipids | 2 | 2024 | 77 | 0.390 |
Why?
| | Heart Diseases | 1 | 2015 | 346 | 0.380 |
Why?
| | Random Allocation | 3 | 2020 | 353 | 0.370 |
Why?
| | Male | 22 | 2025 | 67762 | 0.350 |
Why?
| | Humans | 28 | 2025 | 137585 | 0.330 |
Why?
| | Health Status Disparities | 2 | 2024 | 289 | 0.320 |
Why?
| | Polysomnography | 2 | 2025 | 185 | 0.310 |
Why?
| | Appetite | 2 | 2022 | 69 | 0.300 |
Why?
| | Adipose Tissue | 2 | 2024 | 635 | 0.290 |
Why?
| | Energy Intake | 3 | 2022 | 485 | 0.290 |
Why?
| | Blood Glucose | 9 | 2023 | 2186 | 0.280 |
Why?
| | Dietary Fats | 3 | 2020 | 304 | 0.270 |
Why?
| | Young Adult | 7 | 2025 | 13209 | 0.270 |
Why?
| | Feeding Behavior | 2 | 2025 | 654 | 0.260 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 1060 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2024 | 2531 | 0.250 |
Why?
| | Animals | 14 | 2024 | 36940 | 0.250 |
Why?
| | Adult | 10 | 2025 | 37929 | 0.250 |
Why?
| | Body Mass Index | 2 | 2025 | 2389 | 0.250 |
Why?
| | Glucose Intolerance | 2 | 2020 | 146 | 0.250 |
Why?
| | Venoms | 2 | 2016 | 29 | 0.240 |
Why?
| | Postmenopause | 2 | 2024 | 366 | 0.240 |
Why?
| | Lipolysis | 1 | 2024 | 46 | 0.220 |
Why?
| | Circadian Clocks | 1 | 2023 | 50 | 0.210 |
Why?
| | Female | 12 | 2025 | 73304 | 0.200 |
Why?
| | Portal Vein | 2 | 2014 | 120 | 0.200 |
Why?
| | Fasting | 2 | 2022 | 281 | 0.200 |
Why?
| | Universities | 1 | 2025 | 433 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 2111 | 0.190 |
Why?
| | Leptin | 2 | 2015 | 236 | 0.180 |
Why?
| | Hypoglycemic Agents | 3 | 2016 | 1291 | 0.180 |
Why?
| | Homeostasis | 2 | 2023 | 621 | 0.180 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 697 | 0.180 |
Why?
| | Citric Acid Cycle | 1 | 2021 | 57 | 0.180 |
Why?
| | Subcellular Fractions | 1 | 2021 | 82 | 0.180 |
Why?
| | Body Weight | 4 | 2022 | 985 | 0.180 |
Why?
| | Mitochondria, Muscle | 1 | 2021 | 116 | 0.160 |
Why?
| | Peptides | 2 | 2016 | 985 | 0.160 |
Why?
| | Meals | 1 | 2020 | 125 | 0.150 |
Why?
| | Weight Loss | 1 | 2024 | 787 | 0.150 |
Why?
| | Prevalence | 1 | 2025 | 2734 | 0.140 |
Why?
| | Diet | 2 | 2015 | 1278 | 0.140 |
Why?
| | Denervation | 2 | 2014 | 24 | 0.140 |
Why?
| | Norepinephrine | 2 | 2015 | 204 | 0.130 |
Why?
| | Methyl Ethers | 1 | 2016 | 13 | 0.130 |
Why?
| | Isoflurane | 1 | 2016 | 31 | 0.130 |
Why?
| | Subcutaneous Fat | 1 | 2016 | 81 | 0.120 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2015 | 23 | 0.120 |
Why?
| | Time Factors | 5 | 2025 | 6828 | 0.120 |
Why?
| | Fish Oils | 1 | 2015 | 26 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 762 | 0.120 |
Why?
| | Hydrocortisone | 2 | 2015 | 322 | 0.120 |
Why?
| | Middle Aged | 5 | 2024 | 33479 | 0.120 |
Why?
| | Abdominal Fat | 1 | 2015 | 41 | 0.120 |
Why?
| | Biomarkers | 3 | 2015 | 4149 | 0.120 |
Why?
| | Colorado | 1 | 2025 | 4565 | 0.120 |
Why?
| | Dysbiosis | 1 | 2016 | 181 | 0.110 |
Why?
| | Pregnancy | 2 | 2024 | 6763 | 0.110 |
Why?
| | Human Growth Hormone | 1 | 2015 | 48 | 0.110 |
Why?
| | Receptors, Glucagon | 1 | 2014 | 27 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2015 | 199 | 0.110 |
Why?
| | Risk Factors | 2 | 2025 | 10388 | 0.110 |
Why?
| | Intra-Abdominal Fat | 1 | 2014 | 91 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 253 | 0.100 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 5778 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 382 | 0.100 |
Why?
| | Thinness | 1 | 2012 | 91 | 0.090 |
Why?
| | Up-Regulation | 1 | 2015 | 843 | 0.090 |
Why?
| | Adolescent | 5 | 2024 | 21513 | 0.090 |
Why?
| | Hyperglycemia | 1 | 2014 | 347 | 0.090 |
Why?
| | Hemodynamics | 1 | 2015 | 1113 | 0.080 |
Why?
| | Cohort Studies | 1 | 2021 | 5742 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 437 | 0.080 |
Why?
| | Sympathetic Nervous System | 1 | 2010 | 182 | 0.080 |
Why?
| | Body Composition | 3 | 2020 | 684 | 0.080 |
Why?
| | Hypoglycemia | 1 | 2014 | 445 | 0.080 |
Why?
| | Glucose | 3 | 2023 | 1020 | 0.080 |
Why?
| | Incidence | 1 | 2015 | 2804 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4295 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2057 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2015 | 3566 | 0.060 |
Why?
| | Signal Transduction | 2 | 2024 | 5079 | 0.060 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2025 | 104 | 0.060 |
Why?
| | Glycerol | 1 | 2024 | 94 | 0.060 |
Why?
| | Adipogenesis | 1 | 2024 | 55 | 0.060 |
Why?
| | Isoproterenol | 1 | 2024 | 113 | 0.060 |
Why?
| | Reaction Time | 1 | 2005 | 412 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
| | Memory | 1 | 2005 | 248 | 0.050 |
Why?
| | Liver | 3 | 2016 | 1943 | 0.050 |
Why?
| | Nutritional Status | 1 | 2025 | 350 | 0.050 |
Why?
| | Fitness Trackers | 1 | 2020 | 12 | 0.040 |
Why?
| | Publications | 1 | 2021 | 47 | 0.040 |
Why?
| | Health | 1 | 2021 | 84 | 0.040 |
Why?
| | Disease | 1 | 2021 | 98 | 0.040 |
Why?
| | Actigraphy | 1 | 2020 | 110 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 519 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1502 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1710 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 673 | 0.030 |
Why?
| | Anesthesia, Inhalation | 1 | 2016 | 9 | 0.030 |
Why?
| | Sleep Stages | 1 | 2016 | 47 | 0.030 |
Why?
| | Overweight | 1 | 2020 | 558 | 0.030 |
Why?
| | Propofol | 1 | 2016 | 73 | 0.030 |
Why?
| | Glucagon | 1 | 2016 | 109 | 0.030 |
Why?
| | Sympathectomy, Chemical | 1 | 2014 | 5 | 0.030 |
Why?
| | Omentum | 1 | 2014 | 10 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2014 | 14 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 726 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2014 | 72 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2014 | 137 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 157 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2014 | 82 | 0.030 |
Why?
| | Catecholamines | 1 | 2014 | 98 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 477 | 0.030 |
Why?
| | Intestines | 1 | 2016 | 357 | 0.030 |
Why?
| | Epinephrine | 1 | 2014 | 139 | 0.030 |
Why?
| | Models, Animal | 1 | 2014 | 384 | 0.020 |
Why?
| | Infant | 1 | 2023 | 9465 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2014 | 803 | 0.020 |
Why?
| | United States | 1 | 2025 | 14841 | 0.020 |
Why?
| | Habituation, Psychophysiologic | 1 | 2005 | 55 | 0.010 |
Why?
| | Memory, Short-Term | 1 | 2005 | 250 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 7604 | 0.010 |
Why?
|
|
Broussard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|